Superstring Capital Management LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Superstring Capital Management LP disclosed 27 US equity positions worth $111.8m in its Q3 2024 13F filing. The largest position was ZLAB at 13.5% of the reported book, followed by CYTK and 430.
What did Superstring Capital Management LP own in Q3 2024? Top 27 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ZLAB ZAI LAB LTD | Healthcare | 13.5% | $15.1m | 626,932 | – | |
| 2 | CYTK CYTOKINETICS INC | Healthcare | 10.2% | $11.4m | 215,798 | – | |
| 3 | 430 TERNS PHARMACEUTICALS INC | 10.1% | $11.2m | 1,348,546 | – | ||
| 4 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 8.9% | $10.0m | 227,047 | – | |
| 5 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 8.7% | $9.7m | 949,522 | – | |
| 6 | TIL INSTIL BIO INC | 6.5% | $7.2m | 107,545 | – | ||
| 7 | NVCR NOVOCURE LTD | Healthcare | 5.5% | $6.1m | 392,711 | – | |
| 8 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.2% | $5.8m | 226,684 | – | |
| 9 | FATE FATE THERAPEUTICS INC | Healthcare | 4.6% | $5.1m | 1,466,934 | – | |
| 10 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 4.6% | $5.1m | 337,347 | – | |
| 11 | TNGX TANGO THERAPEUTICS INC | Healthcare | 4.1% | $4.6m | 599,048 | – | |
| 12 | ETNBGBP 89BIO INC | 3.9% | $4.4m | 595,203 | – | ||
| 13 | NKTX NKARTA INC | Healthcare | 3.0% | $3.3m | 740,294 | – | |
| 14 | LEGN LEGEND BIOTECH CORP | Healthcare | 2.6% | $2.9m | 60,515 | – | |
| 15 | ZBIO ZENAS BIOPHARMA INC | 1.7% | $1.9m | 111,605 | – | ||
| 16 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 1.2% | $1.3m | 478,115 | – | |
| 17 | SYRE SPYRE THERAPEUTICS INC | 1.0% | $1.1m | 37,287 | – | ||
| 18 | SVRA SAVARA INC | Healthcare | 0.8% | $848.0k | 200,000 | – | |
| 19 | BMEA BIOMEA FUSION INC | 0.8% | $843.9k | 83,554 | – | ||
| 20 | TRML TOURMALINE BIO INC | 0.7% | $748.3k | 29,104 | – | ||
| 21 | ZURA ZURA BIO LTD | Healthcare | 0.6% | $635.9k | 156,626 | – | |
| 22 | CABA CABALETTA BIO INC | Healthcare | 0.6% | $622.1k | 131,795 | – | |
| 23 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 0.5% | $524.0k | 25,401 | – | |
| 24 | IMVT IMMUNOVANT INC | Healthcare | 0.3% | $354.9k | 12,447 | – | |
| 25 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.3% | $348.9k | 20,840 | – | |
| 26 | LAKESHORE BIOPHARMA CO LTD | 0.2% | $212.2k | 307,920 | – | ||
| 27 | CLYM ELIEM THERAPEUTICS INC | 0.2% | $172.2k | 33,824 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.